Nigerian Innovation GenScanAI Targets Up to 90% Faster MRI Scans, Raises Hopes for Better Diagnostic Access

 
By Simpson Global Media News Desk

A Nigerian-developed artificial intelligence innovation is drawing attention to the potential of home-grown technology to address one of the practical challenges facing healthcare providers: the time required to conduct magnetic resonance imaging examinations.

GenScanAI, developed by Mary-Brenda Akoda, winner of the 2026 Nigeria Prize for Science and Innovation, uses artificial intelligence and advanced computing techniques to accelerate the reconstruction of magnetic resonance imaging (MRI) images. The innovation has been presented as having the potential to reduce MRI scan times by up to 90 per cent without requiring hospitals to purchase new scanning hardware. The technology was showcased to healthcare professionals, researchers, academics and technology stakeholders at Vibranium Valley in Ikeja, Lagos. However, its eventual impact will depend on clinical validation, compatibility with existing equipment and adoption by healthcare providers.

The unveiling has renewed discussion about how Nigerian research and digital technology could improve the efficiency of existing medical infrastructure, particularly in a health system where access to advanced diagnostic services can be limited by equipment availability, cost and patient demand. <Cite refs={["turn547290view0","turn547290view1","turn547290view2"]}/>

An attempt to address a practical healthcare problem

MRI is an important diagnostic tool used by clinicians to examine internal structures of the body. Depending on the part of the body being scanned and the clinical questions being investigated, it can help healthcare professionals assess conditions involving the brain, spine, joints, muscles and other soft tissues.

Although MRI provides valuable diagnostic information, examinations can take considerable time. Patients may need to remain still inside the scanner while multiple images are acquired. Longer examinations can restrict the number of patients a diagnostic centre can accommodate during its operating hours.

This creates a capacity challenge for facilities that serve large patient populations or operate with limited access to expensive diagnostic equipment. If a scanner spends a substantial part of the day examining one patient at a time, other patients may have to wait longer for appointments.

GenScanAI is being developed around this operational problem. Rather than requiring a hospital to begin by purchasing another MRI machine, the technology applies artificial intelligence and advanced computing to the process of reconstructing MRI images. Its stated objective is to make the imaging process faster while maintaining or improving image quality. <Cite refs={["turn547290view0","turn547290view1"]}/>

The distinction matters because the proposed innovation focuses on improving the productivity of existing infrastructure. In principle, technology that reduces examination time could allow a diagnostic facility to use its equipment more efficiently, potentially increasing the number of patients it can serve within a given period.

However, the reported potential to reduce scan time by up to 90 per cent should not be interpreted as a guaranteed outcome for every examination. Actual performance may vary according to the type of scan, the equipment involved, the clinical requirements and the results of further testing.

How artificial intelligence fits into MRI imaging

MRI systems use magnetic fields and radiofrequency signals to generate information that is processed into images of internal body structures. Producing those images involves collecting data and reconstructing it into a form that clinicians can interpret.

GenScanAI applies artificial intelligence and advanced computing to accelerate MRI image reconstruction. The central proposition is that computational techniques can help produce useful images more quickly, potentially reducing the time needed for examinations while preserving the quality required for clinical decisions. <Cite refs={["turn547290view0","turn547290view2"]}/>

This approach is part of a broader area of medical technology in which software is used to improve the performance of existing diagnostic systems. In some applications, AI tools help clinicians analyse images; in others, they support image processing or workflow efficiency. GenScanAI’s reported focus is on the reconstruction process associated with MRI imaging.

That distinction is important. Faster image reconstruction does not automatically establish that every stage of a patient’s examination will become shorter by the same proportion. An MRI appointment may also involve preparation, positioning, safety checks, the acquisition of different image sequences and review of the resulting scans.

The reported reduction of up to 90 per cent therefore needs to be assessed against clearly defined measures. Healthcare providers and independent evaluators would need to understand which examinations were tested, what the comparison baseline was, how image quality was measured and whether the performance could be reproduced across different scanners and patient groups.

The public presentation introduced the innovation to potential users and professional stakeholders. The next stage is to establish, through appropriate evidence, how well it performs in real clinical environments. <Cite refs={["turn547290view0","turn547290view1"]}/>

Why shorter examinations could matter for patients

For patients, the most immediate potential benefit is a reduction in the time spent undergoing a scan.

Remaining still inside an MRI machine can be uncomfortable for some people, especially during longer examinations. Some patients experience anxiety in confined spaces, while others may find it difficult to remain motionless because of pain or other limitations.

A technology that safely shortens an examination could make the experience more manageable for some patients. Reports on GenScanAI have also highlighted its potential to accommodate patient movement and improve image quality, although those possibilities require appropriate clinical evaluation before they can be treated as established benefits. <Cite refs={["turn547290view0","turn547290view2"]}/>

Faster examinations could also help diagnostic centres manage appointment schedules. If the technology proves reliable and reduces the time needed for suitable scans, facilities may be able to accommodate more patients without extending operating hours or immediately investing in additional machines.

For patients waiting for diagnostic appointments, improved capacity could be meaningful. However, shorter scans alone would not eliminate all causes of delay. Appointment availability also depends on staffing, equipment maintenance, power supply, referral processes, reporting capacity and the cost of services.

Nor does faster imaging by itself guarantee earlier treatment. A timely diagnosis depends on the complete pathway: a patient must be able to access the examination, obtain an interpretable scan, receive an appropriate clinical report and reach a healthcare professional who can act on the findings.

GenScanAI’s potential contribution should therefore be assessed as one possible part of a broader effort to improve diagnostic services, rather than a standalone solution to every healthcare access problem.

Potential value for hospitals and diagnostic centres

The innovation could be particularly relevant to facilities seeking to improve the use of expensive MRI equipment.

MRI machines require substantial investment, and operating them involves more than the initial purchase price. Healthcare providers must also maintain the equipment, employ trained staff, provide suitable facilities and manage the operational costs associated with delivering scans.

Where a hospital has significant patient demand but limited scanner availability, improving the efficiency of existing equipment could be an attractive option. If GenScanAI delivers its stated performance under clinical conditions, facilities could potentially examine more patients during existing operating hours.

Such a result might reduce pressure on appointment schedules and improve equipment utilisation. It could also give healthcare administrators another option to evaluate alongside purchasing new machines, expanding operating hours or referring patients to other centres.

But the financial case must be demonstrated rather than assumed. Hospitals would need reliable information about implementation costs, software or computing requirements, maintenance, staff training and compatibility with their existing MRI systems.

They would also need to determine whether the technology produces consistent results across the examinations they routinely perform. A system that works effectively for one scan type may not necessarily produce the same time savings for every other type.

The financial benefit would ultimately depend on whether the gains in throughput and efficiency outweigh the costs of adopting and maintaining the technology. <Cite refs={["turn547290view0","turn547290view2"]}/>

Image quality and patient safety must remain central

Speed is only one measure of a successful medical imaging technology. The images must also be suitable for their intended clinical purpose.

An examination that finishes more quickly but fails to provide the information required by a clinician would not represent meaningful progress. Any technology used in MRI workflows must therefore be evaluated for image quality, reliability and its suitability for the clinical decisions that depend on the results.

For GenScanAI, the claim that image quality can be maintained or improved is an important part of its reported potential. Independent testing would help establish how that performance holds up across different types of examination and under the varied conditions encountered in hospitals and diagnostic centres.

Clinical evaluation should also examine whether the technology introduces limitations that users need to understand. Healthcare professionals would need clear guidance on the circumstances in which it can be used, how its output should be assessed and when conventional imaging protocols or additional sequences remain necessary.

These safeguards are especially important because medical images inform decisions about diagnosis, further investigation and treatment. Technology should support clinical practice without encouraging providers to prioritise speed over the quality of evidence available to clinicians.

The public reports on the unveiling describe GenScanAI’s promise and potential applications, but they do not establish that the technology has already achieved widespread clinical deployment or that its reported performance has been independently confirmed across routine hospital settings. <Cite refs={["turn547290view0","turn547290view1"]}/>

The role of NLNG and the Nigeria Prize for Science and Innovation

The innovation was presented publicly with support from Nigeria LNG Limited (NLNG), which facilitates the Nigeria Prizes. The event at Vibranium Valley brought together healthcare professionals, researchers, academics, students and technology stakeholders to examine the technology and discuss its possible applications.

According to reports on the presentation, NLNG’s General Manager for External Relations and Sustainable Development, Sophia Horsfall, said medical imaging plays an important role in diagnosis and treatment, but the time required for examinations can delay patients and constrain the number of people healthcare facilities can serve.

The presentation was intended to take the winning innovation beyond the award process by creating opportunities for engagement between its developer and people who could assess or potentially use the technology. <Cite refs={["turn547290view0","turn547290view2"]}/>

Akoda was selected as the 2026 Nigeria Prize for Science and Innovation winner following the evaluation of more than 230 entries, according to reports. The competition’s theme was “Innovations in Artificial Intelligence or ICT or Digital Technologies for Development,” placing emphasis on the use of digital technology to address practical development challenges. <Cite refs={["turn547290view1","turn547290view2"]}/>

The recognition gives GenScanAI a platform for wider visibility. But an award and a public unveiling are different from routine clinical adoption. Moving from a promising innovation to a technology used reliably in hospitals requires technical evaluation, appropriate clinical evidence, implementation planning and sustained engagement with healthcare providers.

From demonstration to practical deployment

The key question now is how GenScanAI will progress from its public presentation towards practical use.

One important step is to establish a clear evidence base for the reported performance. This includes documenting the types of MRI examinations tested, the time required before and after using the technology, the methods used to assess image quality and the conditions under which the results were obtained.

Another is technical compatibility. Diagnostic centres use different MRI systems and clinical workflows. Prospective users will need to know which systems GenScanAI supports, what additional computing or software infrastructure may be required and whether integration would disrupt existing services.

Clinical validation is equally important. Healthcare providers need evidence that the technology can produce reliable images for the intended examinations and that its use fits established patient-safety and clinical quality requirements.

Operational questions also matter. Facilities will need to understand who will support the system, how updates will be managed, how staff will be trained and what happens if the technology becomes unavailable. Clear processes for technical failures and quality checks are essential in environments where diagnostic services support time-sensitive medical decisions.

Finally, hospitals will need a credible cost and implementation model. Even if a technology avoids the need to purchase new MRI hardware, adoption may still involve expenses related to software, computing, integration, training and ongoing support.

These are not reasons to dismiss the innovation. They are the practical steps that help determine whether an encouraging technology can become a dependable healthcare tool.

What it could mean for Nigeria’s technology ecosystem

GenScanAI also illustrates a broader opportunity for Nigerian researchers and technology developers: applying advanced computing to problems that institutions already face.

Artificial intelligence is often discussed in terms of chatbots, automated content or general-purpose digital assistants. Its potential applications are much wider. In healthcare, AI may help with image processing, workflow optimisation and other tasks where reliable computing can support professionals and make existing systems more efficient.

A locally developed innovation aimed at a real diagnostic bottleneck could attract interest from hospitals, research institutions, technology investors and healthcare operators. If its effectiveness is demonstrated, it may also provide a basis for further research into how AI can support diagnostic infrastructure.

Yet the development of a sustainable health technology sector requires more than a successful demonstration. It depends on rigorous evaluation, technical expertise, financing, regulatory clarity and partnerships between developers and the institutions that will use their products.

It also requires realistic communication. Claims about performance should be specific enough for hospitals and patients to understand what has been tested, what remains under evaluation and what benefits can reasonably be expected.

The most meaningful measure of GenScanAI’s success will not be the attention generated by its unveiling alone. It will be whether the technology can demonstrate reliable performance and deliver measurable improvements in diagnostic services.

The next milestone is evidence

GenScanAI presents an encouraging example of Nigerian innovation directed at a practical problem in healthcare. By using AI and advanced computing to accelerate MRI image reconstruction, it seeks to improve the efficiency of existing diagnostic equipment and potentially reduce the time patients spend undergoing scans.

Its reported potential to reduce scan times by up to 90 per cent has attracted attention, particularly because the approach is presented as not requiring new MRI hardware. If the performance is confirmed and the technology is adopted appropriately, it could help some facilities improve patient throughput and make better use of their equipment.

For now, that potential must be distinguished from proven outcomes across routine clinical practice. The available reports describe the technology’s unveiling and proposed benefits, while highlighting the need for further evaluation and validation.

For Nigeria’s technology and healthcare sectors, the next stage is clear: establish the evidence, test the technology in appropriate clinical settings and determine how it can be integrated safely and sustainably into existing services.

If those steps are successful, GenScanAI could become an example of how locally developed digital technology can move beyond a prize-winning concept towards a practical contribution to healthcare delivery.